Crosstalk between Wnt and bone morphogenic protein signaling: A turbulent relationship

Developmental Dynamics

Volumn 239, Issue 1, 2010, Pages 16-33

  Itasaki, Nobue ^a   Hoppler, Stefan ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

BMP; Cancer; Crosstalk; Drosophila; Organogenesis; Patterning; Signaling; Stem cell; Vertebrate embryos; Wnt

Indexed keywords

BONE MORPHOGENETIC PROTEIN; WNT PROTEIN;

BONE DEVELOPMENT; CANCER GROWTH; DROSOPHILA; EMBRYO DEVELOPMENT; ENDODERM; EVOLUTION; GENE EXPRESSION REGULATION; HEAD; KIDNEY DEVELOPMENT; LIMB DEVELOPMENT; MESODERM; MOLECULAR MECHANICS; NEOPLASM; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD; STEM CELL; TISSUE SPECIFICITY; TOOTH DEVELOPMENT; VERTEBRATE;

ANIMALS; BODY PATTERNING; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, HOMEOBOX; MODELS, BIOLOGICAL; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; STEM CELLS; WNT PROTEINS;

VERTEBRATA;

EID: 73949136201     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22009     Document Type: Review

References (221)

1. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. 2002. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4:599-604.
2. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16:2813-2828.
3. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, McCrea PD, de Crombrugghe B. 2004. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18:1072-1087.
4. Alvarez-Medina R, Cayuso J, Okubo T, Takada S, Marti E. 2008. Wnt canonical pathway restricts graded Shh/Gli patterning activity through the regulation of Gli3 expression. Development 135:237-247.
5. Amedee J, Bareille R, Rouais F, Cunningham N, Reddi H, Harmand MF. 1994. Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow. Differentiation 58:157-164.
6. Arias AM, Hayward P. 2006. Filtering transcriptional noise during development: concepts and mechanisms. Nat Rev Genet 7:34-44.
7. Azpiazu N, Lawrence PA, Vincent JP, Frasch M. 1996. Segmentation and specification of the Drosophila mesoderm. Genes Dev 10:3183-3194.
8. Bachiller D, Klingensmith J, Kemp C, Belo JA, Anderson RM, May SR, McMahon JA, McMahon AP, Harland RM, Rossant J, De Robertis EM. 2000. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature 403:658-661.
9. Bain G, Muller T, Wang X, Papkoff J. 2003. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys Res Commun 301:84-91.
10. Barker N, Morin PJ, Clevers H. 2000. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res 77:1-24.
11. Baron R, Rawadi G, Roman-Roman S. 2006. Wnt signaling: a key regulator of bone mass. Curr Top Dev Biol 76:103-127.
12. Basler K, Edlund T, Jessell TM, Yamada T. 1993. Control of cell pattern in the neural tube: regulation of cell differentiation by dorsalin-1, a novel TGF beta family member. Cell 73:687-702.
13. Batts LE, Polk DB, Dubois RN, Kulessa H. 2006. Bmp signaling is required for intestinal growth and morphogenesis. Dev Dyn 235:1563-1570.
14. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. 1999. Sox9 is required for cartilage formation. Nat Genet 22:85-89.
15. Bienz M. 1997. Endoderm induction in Drosophila: the nuclear targets of the inducing signals. Curr Opin Genet Dev 7:683-688.
16. Blish KR, Wang W, Willingham MC, Du W, Birse CE, Krishnan SR, Brown JC, Hawkins GA, Garvin AJ, D'Agostino RB Jr, Torti FM, Torti SV. 2008. A human bone morphogenetic protein antagonist is down-regulated in renal cancer. Mol Biol Cell 19:457-464.
17. Bonafede A, Kohler T, Rodriguez-Niedenfuhr M, Brand-Saberi B. 2006. BMPs restrict the position of premuscle masses in the limb buds by influencing Tcf4 expression. Dev Biol 299:330-344.
18. Bonner J, Gribble SL, Veien ES, Nikolaus OB, Weidinger G, Dorsky RI. 2008. Proliferation and patterning are mediated independently in the dorsal spinal cord downstream of canonical Wnt signaling. Dev Biol 313:398-407.
19. Bouhon IA, Kato H, Chandran S, Allen ND. 2005. Neural differentiation of mouse embryonic stem cells in chemically defined medium. Brain Res Bull 68:62-75.
20. Bouwmeester T, Kim S, Sasai Y, Lu B, De Robertis EM. 1996. Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer. Nature 382:595-601.
21. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521.
22. Brabletz S, Schmalhofer O, Brabletz T. 2009. Gastrointestinal stem cells in development and cancer. J Pathol 217:307-317.
23. Bridgewater D, Cox B, Cain J, Lau A, Athaide V, Gill PS, Kuure S, Sainio K, Rosenblum ND. 2008. Canonical WNT/beta-catenin signaling is required for ureteric branching. Dev Biol 317:83-94.
24. Burstyn-Cohen T, Stanleigh J, Sela-Donenfeld D, Kalcheim C. 2004. Canonical Wnt activity regulates trunk neural crest delamination linking BMP/noggin signaling with G1/S transition. Development 131:5327-5339.
25. Cantley LC, Neel BG. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 96:4240-4245.
26. Carmena A, Gisselbrecht S, Harrison J, Jimenez F, Michelson AM. 1998. Combinatorial signaling codes for the progressive determination of cell fates in the Drosophila embryonic mesoderm. Genes Dev 12:3910-3922.
27. Carroll TJ, Park JS, Hayashi S, Majumdar A, McMahon AP. 2005. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 9:283-292.
28. Caruana G, Cullen-McEwen L, Nelson AL, Kostoulias X, Woods K, Gardiner B, Davis MJ, Taylor DF, Teasdale RD, Grimmond SM, Little MH, Bertram JF. 2006. Spatial gene expression in the T-stage mouse metanephros. Gene Expr Patterns 6:807-825.
29. Chesnutt C, Burrus LW, Brown AM, Niswander L. 2004. Coordinate regulation of neural tube patterning and proliferation by TGFbeta and WNT activity. Dev Biol 274:334-347.
30. Cheung M, Briscoe J. 2003. Neural crest development is regulated by the transcription factor Sox9. Development 130:5681-5693.
31. Crease DJ, Dyson S, Gurdon JB. 1998. Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci U S A 95:4398-4403.
32. Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH. 2001. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105:721-732.
33. Dassule HR, McMahon AP. 1998. Analysis of epithelial-mesenchymal interactions in the initial morphogenesis of the mammalian tooth. Dev Biol 202:215-227.
34. Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P, Glinka A, Niehrs C. 2005. Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438:867-872.
35. Day TF, Guo X, Garrett-Beal L, Yang Y. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750.
36. del Barco Barrantes I, Davidson G, Grone HJ, Westphal H, Niehrs C. 2003. Dkk1 and noggin cooperate in mammalian head induction. Genes Dev 17:2239-2244.
37. Delaune E, Lemaire P, Kodjabachian L. 2005. Neural induction in Xenopus requires early FGF signalling in addition to BMP inhibition. Development 132:299-310.
38. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584.
39. Ding VW, Chen RH, McCormick F. 2000. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J Biol Chem 275:32475-32481.
40. Dudley AT, Lyons KM, Robertson EJ. 1995. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807.
41. Edlund S, Lee SY, Grimsby S, Zhang S, Aspenstrom P, Heldin CH, Landstrom M. 2005. Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. Mol Cell Biol 25:1475-1488.
42. Ellies DL, Viviano B, McCarthy J, Rey JP, Itasaki N, Saunders S, Krumlauf R. 2006. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res 21:1738-1749.
43. Estella C, McKay DJ, Mann RS. 2008. Molecular integration of wingless, decapentaplegic, and autoregulatory inputs into Distalless during Drosophila leg development. Dev Cell 14:86-96.
44. Fischer L, Boland G, Tuan RS. 2002. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem 84:816-831.
45. Frame S, Cohen P, Biondi RM. 2001. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7:1321-1327.
46. Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, De Robertis EM. 2007. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131:980-993.
47. Galli LM, Barnes TL, Secrest SS, Kadowaki T, Burrus LW. 2007. Porcupine-mediated lipid-modification regulates the activity and distribution of Wnt proteins in the chick neural tube. Development 134:3339-3348.
48. Ganan Y, Macias D, Duterque-Coquillaud M, Ros MA, Hurle JM. 1996. Role of TGF beta s and BMPs as signals controlling the position of the digits and the areas of interdigital cell death in the developing chick limb autopod. Development 122:2349-2357.
49. Gaulden J, Reiter JF. 2008. Neur-ons and neur-offs: regulators of neural induction in vertebrate embryos and embryonic stem cells. Hum Mol Genet 17:R60-R66.
50. Giles RH, van Es JH, Clevers H. 2003. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653:1-24.
51. Glass DA Jr, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751-764.
52. Glinka A, Wu W, Onichtchouk D, Blumenstock C, Niehrs C. 1997. Head induction by simultaneous repression of Bmp and Wnt signalling in Xenopus. Nature 389:517-519.
53. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. 1998. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391:357-362.
54. Gomez-Skarmeta J, de La Calle-Mustienes E, Modolell J. 2001. The Wnt-activated Xiro1 gene encodes a repressor that is essential for neural development and downregulates Bmp4. Development 128:551-560.
55. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
56. Gordon MD, Nusse R. 2006. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429-22433.
57. Gould SE, Day M, Jones SS, Dorai H. 2002. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61:51-60.
58. Gowan K, Helms AW, Hunsaker TL, Collisson T, Ebert PJ, Odom R, Johnson JE. 2001. Crossinhibitory activities of Ngn1 and Math1 allow specification of distinct dorsal interneurons. Neuron 31:219-232.
59. Guha U, Gomes WA, Kobayashi T, Pestell RG, Kessler JA. 2002. In vivo evidence that BMP signaling is necessary for apoptosis in the mouse limb. Dev Biol 249:108-120.
60. Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, Sun LZ, Ahlquist DA, Wood CG, Copland JA. 2007. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 13:4740-4749.
61. Han G, Li AG, Liang YY, Owens P, He W, Lu S, Yoshimatsu Y, Wang D, Ten Dijke P, Lin X, Wang XJ. 2006. Smad7-induced beta-catenin degradation alters epidermal appendage development. Dev Cell 11:301-312.
62. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H, Force T. 2003. Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci U S A 100:4610-4615.
63. Haramis AP, Begthel H, van den Born M, van Es J, Jonkheer S, Offerhaus GJ, Clevers H. 2004. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303:1684-1686.
64. Hardwick JC, Kodach LL, Offerhaus GJ, van den Brink GR. 2008. Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer 8:806-812.
65. Hartmann C. 2006. A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol 16:151-158.
66. Hartmann C. 2007. Skeletal development - Wnts are in control. Mol Cells 24:177-184.
67. Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massague J. 2000. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100:229-240.
68. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, Wiedemann LM, Mishina Y, Li L. 2004. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 36:1117-1121.
69. Helms AW, Johnson JE. 2003. Specification of dorsal spinal cord interneurons. Curr Opin Neurobiol 13:42-49.
70. Hemmati-Brivanlou A, Melton D. 1997. Vertebrate embryonic cells will become nerve cells unless told otherwise. Cell 88:13-17.
71. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. 2005. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727-738.
72. Hill TP, Taketo MM, Birchmeier W, Hartmann C. 2006. Multiple roles of mesenchymal beta-catenin during murine limb patterning. Development 133:1219-1229.
73. Hoang B, Moos M Jr, Vukicevic S, Luyten FP. 1996. Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem 271:26131-26137.
74. Hohenstein P, Molenaar L, Elsinga J, Morreau H, van der Klift H, Struijk A, Jagmohan-Changur S, Smits R, van Kranen H, van Ommen GJ, Cornelisse C, Devilee P, Fodde R. 2003. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene. Genes Chromosomes Cancer 36:273-282.
75. Hollyday M, McMahon JA, McMahon AP. 1995. Wnt expression patterns in chick embryo nervous system. Mech Dev 52:9-25.
76. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL, Williams BO. 2005. Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 280:21162-21168.
77. Hoppler S, Bienz M. 1994. Specification of a single cell type by a Drosophila homeotic gene. Cell 76:689-702.
78. Hoppler S, Bienz M. 1995. Two different thresholds of wingless signalling with distinct developmental consequences in the Drosophila midgut. EMBO J 14:5016-5026.
79. Hoppler S, Kavanagh CL. 2007. Wnt signalling: variety at the core. J Cell Sci 120:385-393.
80. Hoppler S, Moon RT. 1998. BMP-2/-4 and Wnt-8 cooperatively pattern the Xenopus mesoderm. Mech Dev 71:119-129.
81. Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, Tomlinson IP, Houlston RS, Bevan S, Mitros FA, Stone EM, Aaltonen LA. 1998. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280:1086-1088.
82. Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, Velculescu VE, Traverso G, Vogelstein B. 2001. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28:184-187.
83. Hu MC, Rosenblum ND. 2005. Smad1, {beta}-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development 132:215-225.
84. Hu MC, Piscione TD, Rosenblum ND. 2003. Elevated SMAD1/beta-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice. Development 130:2753-2766.
85. Huang H, He X. 2008. Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol 20:119-125.
86. Hughes FJ, Collyer J, Stanfield M, Goodman SA. 1995. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 136:2671-2677.
87. Hussein SM, Duff EK, Sirard C. 2003. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 278:48805-48814.
88. Ille F, Atanasoski S, Falk S, Ittner LM, Marki D, Buchmann-Moller S, Wurdak H, Suter U, Taketo MM, Sommer L. 2007. Wnt/BMP signal integration regulates the balance between proliferation and differentiation of neuroepithelial cells in the dorsal spinal cord. Dev Biol 304:394-408.
89. Im J, Kim H, Kim S, Jho EH. 2007. Wnt/beta-catenin signaling regulates expression of PRDC, an antagonist of the BMP-4 signaling pathway. Biochem Biophys Res Commun 354:296-301.
90. Itaranta P, Lin Y, Perasaari J, Roel G, Destree O, Vainio S. 2002. Wnt-6 is expressed in the ureter bud and induces kidney tubule development in vitro. Genesis 32:259-268.
91. Itasaki N, Jones CM, Mercurio S, Rowe A, Domingos PM, Smith JC, Krumlauf R. 2003. Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 130:4295-4305.
92. Jamora C, DasGupta R, Kocieniewski P, Fuchs E. 2003. Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 422:317-322.
93. Jarvinen E, Salazar-Ciudad I, Birchmeier W, Taketo MM, Jernvall J, Thesleff I. 2006. Continuous tooth generation in mouse is induced by activated epithelial Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 103:18627-18632.
94. Jian H, Shen X, Liu I, Semenov M, He X, Wang XF. 2006. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 20:666-674.
95. Jin EJ, Erickson CA, Takada S, Burrus LW. 2001. Wnt and BMP signaling govern lineage segregation of melanocytes in the avian embryo. Dev Biol 233:22-37.
96. Jin EJ, Lee SY, Choi YA, Jung JC, Bang OS, Kang SS. 2006. BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway. Mol Cells 22:353-359.
97. Johnson EB, Hammer RE, Herz J. 2005. Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. Hum Mol Genet 14:3523-3538.
98. Kassai Y, Munne P, Hotta Y, Penttila E, Kavanagh K, Ohbayashi N, Takada S, Thesleff I, Jernvall J, Itoh N. 2005. Regulation of mammalian tooth cusp patterning by ectodin. Science 309:2067-2070.
99. Kawakami Y, Capdevila J, Buscher D, Itoh T, Rodriguez Esteban C, Izpisua Belmonte JC. 2001. WNT signals control FGF-dependent limb initiation and AER induction in the chick embryo. Cell 104:891-900.
100. Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R. 2008. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer 123:535-542.
101. Kengaku M, Capdevila J, Rodriguez-Esteban C, De La Pena J, Johnson RL, Belmonte JC, Tabin CJ. 1998. Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science 280:1274-1277.
102. Kikuchi A. 2003. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 94:225-229.
103. Kim JS, Crooks H, Dracheva T, Nishanian TG, Singh B, Jen J, Waldman T. 2002. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res 62:2744-2748.
104. Kleber M, Sommer L. 2004. Wnt signaling and the regulation of stem cell function. Curr Opin Cell Biol 16:681-687.
105. Kleber M, Lee HY, Wurdak H, Buchstaller J, Riccomagno MM, Ittner LM, Suter U, Epstein DJ, Sommer L. 2005. Neural crest stem cell maintenance by combinatorial Wnt and BMP signaling. J Cell Biol 169:309-320.
106. Knirr S, Frasch M. 2001. Molecular integration of inductive and mesoderm-intrinsic inputs governs even-skipped enhancer activity in a subset of pericardial and dorsal muscle progenitors. Dev Biol 238:13-26.
107. Korchynskyi O, ten Dijke P. 2002. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277:4883-4891.
108. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275:1784-1787.
109. Kosinski C, Li VS, Chan AS, Zhang J, Ho C, Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST, Leung SY, Chen X. 2007. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci U S A 104:15418-15423.
110. Kratochwil K, Dull M, Farinas I, Galceran J, Grosschedl R. 1996. Lef1 expression is activated by BMP-4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev 10:1382-1394.
111. Kuroda H, Fuentealba L, Ikeda A, Reversade B, De Robertis EM. 2005. Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. Genes Dev 19:1022-1027.
112. Kusu N, Laurikkala J, Imanishi M, Usui H, Konishi M, Miyake A, Thesleff I, Itoh N. 2003. Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J Biol Chem 278:24113-24117.
113. Labbe E, Letamendia A, Attisano L. 2000. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A 97:8358-8363.
114. Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, Pirinen S, Nieminen P. 2004. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 74:1043-1050.
115. Laurikkala J, Kassai Y, Pakkasjarvi L, Thesleff I, Itoh N. 2003. Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot. Dev Biol 264:91-105.
116. Lee HH, Frasch M. 2005. Nuclear integration of positive Dpp signals, antagonistic Wg inputs and mesodermal competence factors during Drosophila visceral mesoderm induction. Development 132:1429-1442.
117. Lee KJ, Mendelsohn M, Jessell TM. 1998. Neuronal patterning by BMPs: a requirement for GDF7 in the generation of a discrete class of commissural interneurons in the mouse spinal cord. Genes Dev 12:3394-3407.
118. Lee HX, Ambrosio AL, Reversade B, De Robertis EM. 2006. Embryonic dorsal-ventral signaling: secreted frizzled-related proteins as inhibitors of tolloid proteinases. Cell 124:147-159.
119. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. 1997. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346.
120. Lei S, Dubeykovskiy A, Chakladar A, Wojtukiewicz L, Wang TC. 2004. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways. J Biol Chem 279:42492-42502.
121. Letamendia A, Labbe E, Attisano L. 2001. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 83(suppl 1):S31-S39.
122. X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D. 2005. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19883-19887.
123. Liem KF Jr, Tremml G, Roelink H, Jessell TM. 1995. Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 82:969-979.
124. Liem KF Jr, Tremml G, Jessell TM. 1997. A role for the roof plate and its resident TGFbeta-related proteins in neuronal patterning in the dorsal spinal cord. Cell 91:127-138.
125. Linker C, Stern CD. 2004. Neural induction requires BMP inhibition only as a late step, and involves signals other than FGF and Wnt antagonists. Development 131:5671-5681.
126. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML. 2002. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19.
127. Liu Z, Tang Y, Qiu T, Cao X, Clemens TL. 2006. A dishevelled-1/Smad1 interaction couples WNT and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells. J Biol Chem 281:17156-17163.
128. Liu B, Yu HM, Hsu W. 2007. Craniosynostosis caused by Axin2 deficiency is mediated through distinct functions of beta-catenin in proliferation and differentiation. Dev Biol 301:298-308.
129. Liu F, Chu EY, Watt B, Zhang Y, Gallant NM, Andl T, Yang SH, Lu MM, Piccolo S, Schmidt-Ullrich R, Taketo MM, Morrisey EE, Atit R, Dlugosz AA, Millar SE. 2008. Wnt/beta-catenin signaling directs multiple stages of tooth morphogenesis. Dev Biol 313:210-224.
130. Logan CY, Nusse R. 2004. The Wnt signaling pathway in development and disease. Ann Rev Cell Dev Biol 20:781-810.
131. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G. 1995. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820.
132. Maehama T, Dixon JE. 1999. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol 9:125-128.
133. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP. 2007. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315:1278-1282.
134. Marazzi G, Wang Y, Sassoon D. 1997. Msx2 is a transcriptional regulator in the BMP4-mediated programmed cell death pathway. Dev Biol 186:127-138.
135. Martinez G, Loveland KL, Clark AT, Dziadek M, Bertram JF. 2001. Expression of bone morphogenetic protein receptors in the developing mouse metanephros. Exp Nephrol 9:372-379.
136. Mathies LD, Kerridge S, Scott MP. 1994. Role of the teashirt gene in Drosophila midgut morphogenesis: secreted proteins mediate the action of homeotic genes. Development 120:2799-2809.
137. Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC. 2004. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131:2137-2147.
138. Mitu GM, Wang S, Hirschberg R. 2007. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol Renal Physiol 293:F1641-1648.
139. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. 2004. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5:691-701.
140. Mukhopadhyay M, Shtrom S, Rodriguez-Esteban C, Chen L, Tsukui T, Gomer L, Dorward DW, Glinka A, Grinberg A, Huang SP, Niehrs C, Belmonte JC, Westphal H. 2001. Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev Cell 1:423-434.
141. Munne PM, Tummers M, Jarvinen E, Thesleff I, Jernvall J. 2009. Tinkering with the inductive mesenchyme: Sostdc1 uncovers the role of dental mesenchyme in limiting tooth induction. Development 136:393-402.
142. Murashima-Suginami A, Takahashi K, Kawabata T, Sakata T, Tsukamoto H, Sugai M, Yanagita M, Shimizu A, Sakurai T, Slavkin HC, Bessho K. 2007. Rudiment incisors survive and erupt as supernumerary teeth as a result of USAG-1 abrogation. Biochem Biophys Res Commun 359:549-555.
143. Muroyama Y, Fujihara M, Ikeya M, Kondoh H, Takada S. 2002. Wnt signaling plays an essential role in neuronal specification of the dorsal spinal cord. Genes Dev 16:548-553.
144. Mutter GL. 2001. Pten, a protean tumor suppressor. Am J Pathol 158:1895-1898.
145. Nguyen VH, Trout J, Connors SA, Andermann P, Weinberg E, Mullins MC. 2000. Dorsal and intermediate neuronal cell types of the spinal cord are established by a BMP signaling pathway. Development 127:1209-1220.
146. Nicholson KM, Anderson NG. 2002. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14:381-395.
147. Niehrs C. 2004. Regionally specific induction by the Spemann-Mangold organizer. Nat Rev Genet 5:425-434.
148. Nishanian TG, Kim JS, Foxworth A, Waldman T. 2004. Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells. Cancer Biol Ther 3:667-675.
149. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. 2000. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403:781-785.
150. Nusse R. 2008. Wnt signaling and stem cell control. Cell Res 18:523-527.
151. Ohazama A, Johnson EB, Ota MS, Choi HJ, Porntaveetus T, Oommen S, Itoh N, Eto K, Gritli-Linde A, Herz J, Sharpe PT. 2008. Lrp4 modulates extracellular integration of cell signaling pathways in development. PLoS ONE 3:e4092.
152. Oshima T, Abe M, Asano J, Hara T, Kitazoe K, Sekimoto E, Tanaka Y, Shibata H, Hashimoto T, Ozaki S, Kido S, Inoue D, Matsumoto T. 2005. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood 106:3160-3165.
153. Pera EM, Ikeda A, Eivers E, De Robertis EM. 2003. Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev 17:3023-3028.
154. Perantoni AO. 2003. Renal development: perspectives on a Wnt-dependent process. Semin Cell Dev Biol 14:201-208.
155. Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S. 2001. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol 153:1161-1174.
156. Piscione TD, Phan T, Rosenblum ND. 2001. BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways. Am J Physiol Renal Physiol 280:F19-F33.
157. Plikus M, Wang WP, Liu J, Wang X, Jiang TX, Chuong CM. 2004. Morpho-regulation of ectodermal organs: integument pathology and phenotypic variations in K14-Noggin engineered mice through modulation of bone morphogenic protein pathway. Am J Pathol 164:1099-1114.
158. Ramel MC, Buckles GR, Baker KD, Lekven AC. 2005. WNT8 and BMP2B co-regulate non-axial mesoderm patterning during zebrafish gastrulation. Dev Biol 287:237-248.
159. Rastegar S, Friedle H, Frommer G, Knochel W. 1999. Transcriptional regulation of Xvent homeobox genes. Mech Dev 81:139-149.
160. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. 2003. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18:1842-1853.
161. Riese J, Yu X, Munnerlyn A, Eresh S, Hsu SC, Grosschedl R, Bienz M. 1997. LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 88:777-787.
162. Rodda SJ, McMahon AP. 2006. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133:3231-3244.
163. Sakai D, Tanaka Y, Endo Y, Osumi N, Okamoto H, Wakamatsu Y. 2005. Regulation of Slug transcription in embryonic ectoderm by beta-catenin-Lef/Tcf and BMP-Smad signaling. Dev Growth Differ 47:471-482.
164. Salic AN, Kroll KL, Evans LM, Kirschner MW. 1997. Sizzled: a secreted Xwnt8 antagonist expressed in the ventral marginal zone of Xenopus embryos. Development 124:4739-4748.
165. Saller E, Kelley A, Bienz M. 2002. The transcriptional repressor Brinker antagonizes Wingless signaling. Genes Dev 16:1828-1838.
166. Sancho E, Batlle E, Clevers H. 2003. Live and let die in the intestinal epithelium. Curr Opin Cell Biol 15:763-770.
167. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J. 2007. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25:441-454.
168. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. 2004. Maintenance of pluripotency in human and mouse embryonic stem cells through
169. Schedl A, Hastie ND. 2000. Cross-talk in kidney development. Curr Opin Genet Dev 10:543-549.
170. Schohl A, Fagotto F. 2002. Beta-catenin, MAPK and Smad signaling during early Xenopus development. Development 129:37-52.
171. Sekiya T, Adachi S, Kohu K, Yamada T, Higuchi O, Furukawa Y, Nakamura Y, Nakamura T, Tashiro K, Kuhara S, Ohwada S, Akiyama T. 2004. Identification of BMP and activin membranebound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem 279:6840-6846.
172. Semenov M, Tamai K, He X. 2005. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 280:26770-26775.
173. Silva AC, Filipe M, Kuerner KM, Steinbeisser H, Belo JA. 2003. Endogenous Cerberus activity is required for anterior head specification in Xenopus. Development 130:4943-4953.
174. Soshnikova N, Zechner D, Huelsken J, Mishina Y, Behringer RR, Taketo MM, Crenshaw EB III, Birchmeier W. 2003. Genetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsalventral axis in the limb. Genes Dev 17:1963-1968.
175. Spemann H, Mangold H. 1924. Ü ber Induktion von Embryonanlagen durch Implantation artfremder Organisatoren. Roux' Arch Entwicklungsmechanik Org 100:599-638.
176. Stark K, Vainio S, Vassileva G, McMahon AP. 1994. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372:679-683.
177. Stern CD, Charite J, Deschamps J, Duboule D, Durston AJ, Kmita M, Nicolas JF, Palmeirim I, Smith JC, Wolpert L. 2006. Head-tail patterning of the vertebrate embryo: one, two or many unresolved problems? Int J Dev Biol 50:3-15.
178. Streit A, Berliner AJ, Papanayotou C, Sirulnik A, Stern CD. 2000. Initiation of neural induction by FGF signalling before gastrulation. Nature 406:74-78.
179. Suzuki A, Thies RS, Yamaji N, Song JJ, Wozney JM, Murakami K, Ueno N. 1994. A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. Proc Natl Acad Sci U S A 91:10255-10259.
180. Szeto DP, Kimelman D. 2004. Combinatorial gene regulation by Bmp and Wnt in zebrafish posterior mesoderm formation. Development 131:3751-3760.
181. Szuts D, Eresh S, Bienz M. 1998. Functional intertwining of Dpp and EGFR signaling during Drosophila endoderm induction. Genes Dev 12:2022-2035.
182. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. 1998. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92:645-656.
183. Takebayashi H, Ohtsuki T, Uchida T, Kawamoto S, Okubo K, Ikenaka K, Takeichi M, Chisaka O, Nabeshima Y. 2002. Non-overlapping expression of Olig3 and Olig2 in the embryonic neural tube. Mech Dev 113:169-174.
184. Tang Y, Liu Z, Zhao L, Clemens TL, Cao X. 2008. Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J Biol Chem 283:23956-23963.
185. ten Dijke P, Krause C, de Gorter DJ, Lowik CW, van Bezooijen RL. 2008. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. J Bone Joint Surg Am 90(suppl 1):31-35.
186. Theil T, Aydin S, Koch S, Grotewold L, Ruther U. 2002. Wnt and Bmp signalling cooperatively regulate graded Emx2 expression in the dorsal telencephalon. Development 129:3045-3054.
187. Theisen H, Haerry TE, O'Connor MB, Marsh JL. 1996. Developmental territories created by mutual antagonism between Wingless and Decapentaplegic. Development 122:3939-3948.
188. Tickle C. 2006. Making digit patterns in the vertebrate limb. Nat Rev Mol Cell Biol 7:45-53.
189. Timmer JR, Wang C, Niswander L. 2002. BMP signaling patterns the dorsal and intermediate neural tube via regulation of homeobox and helix-loop-helix transcription factors. Development 129:2459-2472.
190. Tsuneizumi K, Nakayama T, Kamoshida Y, Kornberg TB, Christian JL, Tabata T. 1997. Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature 389:627-631.
191. Tucker AS, Sharpe PT. 1999. Molecular genetics of tooth morphogenesis and patterning: the right shape in the right place. J Dent Res 78:826-834.
192. van Bezooijen RL, Roelen BA, Visser A, van der Wee-Pals L, de Wilt E, Karperien M, Hamersma H, Papapoulos SE, ten Dijke P, Lowik CW. 2004. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199:805-814.
193. van Bezooijen RL, Svensson JP, Eefting D, Visser A, van der Horst G, Karperien M, Quax PH, Vrieling H, Papapoulos SE, ten Dijke P, Lowik CW. 2007. Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. J Bone Miner Res 22:19-28.
194. van Genderen C, Okamura RM, Farinas I, Quo RG, Parslow TG, Bruhn L, Grosschedl R. 1994. Development of several organs that require inductive epithelialmesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 8:2691-2703.
195. Varga AC, Wrana JL. 2005. The disparate role of BMP in stem cell biology. Oncogene 24:5713-5721.
196. von Bubnoff A, Cho KW. 2001. Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev Biol 239:1-14.
197. von Bubnoff A, Peiffer DA, Blitz IL, Hayata T, Ogata S, Zeng Q, Trunnell M, Cho KW. 2005. Phylogenetic footprinting and genome scanning identify vertebrate BMP response elements and new target genes. Dev Biol 281:210-226.
198. Waltzer L, Vandel L, Bienz M. 2001. Teashirt is required for transcriptional repression mediated by high Wingless levels. EMBO J 20:137-145.
199. Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA. 2003. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63:2037-2049.
200. Warner DR, Greene RM, Pisano MM. 2005a. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells. FEBS Lett 579:3539-3546.
201. Warner DR, Greene RM, Pisano MM. 2005b. Interaction between Smad 3 and Dishevelled in murine embryonic craniofacial mesenchymal cells. Orthod Craniofac Res 8:123-130.
202. Willert J, Epping M, Pollack JR, Brown PO, Nusse R. 2002. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2:8.
203. Wilson SI, Graziano E, Harland R, Jessell TM, Edlund T. 2000. An early requirement for FGF signalling in the acquisition of neural cell fate in the chick embryo. Curr Biol 10:421-429.
204. Wilson SI, Rydstrom A, Trimborn T, Willert K, Nusse R, Jessell TM, Edlund T. 2001. The status of Wnt signalling regulates neural and epidermal fates in the chick embryo. Nature 411:325-330.
205. Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA. 2003. Osteocyte control of bone formation via sclerostin, a novelBMP antagonist. EMBO J 22:6267-6276.
206. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534.
207. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schutz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G. 2008. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825-837.
208. Yanagita M. 2006. Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Kidney Int 70:989-993.
209. Yanagita M, Oka M, Watabe T, Iguchi H, Niida A, Takahashi S, Akiyama T, Miyazono K, Yanagisawa M, Sakurai T. 2004. USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Biochem Biophys Res Commun 316:490-500.
210. Yanagita M, Okuda T, Endo S, Tanaka M, Takahashi K, Sugiyama F, Kunita S, Takahashi S, Fukatsu A, Yanagisawa M, Kita T, Sakurai T. 2006. Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest 116:70-79.
211. Yang L, Yamasaki K, Shirakata Y, Dai X, Tokumaru S, Yahata Y, Tohyama M, Hanakawa Y, Sayama K, Hashimoto K. 2006. Bone morphogenetic protein-2 modulates Wnt and frizzled expression and enhances the canonical pathway of Wnt signaling in normal keratinocytes. J Dermatol Sci 42:111-119.
212. Ying QL, Nichols J, Chambers I, Smith A. 2003. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115:281-292.
213. Yokouchi Y, Sakiyama J, Kameda T, Iba H, Suzuki A, Ueno N, Kuroiwa A. 1996. BMP-2/-4 mediate programmed cell death in chicken limb buds. Development 122:3725-3734.
214. Yu HM, Jerchow B, Sheu TJ, Liu B, Costantini F, Puzas JE, Birchmeier W, Hsu W. 2005. The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 132:1995-2005.
215. Zechner D, Muller T, Wende H, Walther I, Taketo MM, Crenshaw EB III, Treier M, Birchmeier W, Birchmeier C. 2007. Bmp and Wnt/beta-catenin signals control expression of the transcription factor Olig3 and the specification of spinal cord neurons. Dev Biol 303:181-190.
216. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. 2003. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964-968.
217. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, Okamura H, Woodgett J, He X. 2005. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438:873-877.
218. Zeng YA, Rahnama M, Wang S, Lee W, Verheyen EM. 2008. Inhibition of Drosophila Wg signaling involves competition between Mad and Armadillo/beta-catenin for dTcf binding. PLoS ONE 3:e3893.
219. Zhou G, Lefebvre V, Zhang Z, Eberspaecher H, de Crombrugghe B. 1998. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 273:14989-14997.
220. Zhou XP, Woodford-Richens K, Lehtonen R, Kurose K, Aldred M, Hampel H, Launonen V, Virta S, Pilarski R, Salovaara R, Bodmer WF, Conrad BA, Dunlop M, Hodgson SV, Iwama T, Jarvinen H, Kellokumpu I, Kim JC, Leggett B, Markie D, Mecklin JP, Neale K, Phillips R, Piris J, Rozen P, Houlston RS, Aaltonen LA, Tomlinson IP, Eng C. 2001. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 69:704-711.
221. Zou H, Niswander L. 1996. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272:738-741.